RHJA
Rice Hall James & Associates’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5M | Buy |
2,060,280
+32,712
| +2% | +$293K | 0.99% | 29 |
|
|
2025
Q1 | $15.2M | Sell |
2,027,568
-53,748
| -3% | -$403K | 0.89% | 32 |
|
|
2024
Q4 | $15.7M | Sell |
2,081,316
-82,427
| -4% | -$620K | 0.86% | 33 |
|
|
2024
Q3 | $16.4M | Buy |
2,163,743
+84,102
| +4% | +$639K | 0.89% | 28 |
|
|
2024
Q2 | $12.9M | Sell |
2,079,641
-71,904
| -3% | -$444K | 0.77% | 38 |
|
|
2024
Q1 | $10.9M | Sell |
2,151,545
-45,716
| -2% | -$232K | 0.62% | 45 |
|
|
2023
Q4 | $13.2M | Sell |
2,197,261
-78,377
| -3% | -$469K | 0.76% | 42 |
|
|
2023
Q3 | $16.1M | Buy |
2,275,638
+402,674
| +21% | +$2.85M | 1.02% | 23 |
|
|
2023
Q2 | $13.2M | Buy |
+1,872,964
| New | +$13.2M | 0.75% | 40 |
|